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IN the course of recent experiments on possible radioactive chemotherapeutic
substances (Argus and Hewson, 1954), we foundthatfluorene-2,7-di-(sulfonamido-
2'-naphthalene)-S35 failed to localize in tumor tissue. A reexamination of the
data, however, shows that the compound localized in the livers of normal CAF1/
Jax mice to a greater extent than in the livers of CAF1/Jax mice bearing a
transplanted squamous cell stomach carcinoma. This difference was even more
pronounced for the spleen. Since such a phenomenon, if general, might be of
diagnostic value, it was decided to investigate the following points: could this
effect be demonstrated for other transplanted tumors in other strains and
species, and what is the pattern of distribution of radioactivity in the liver and
spleen ?
MATERIALS AND METHODS
A total ofsixteen male C3H/Jax mice, three to fourmonths old, were employed.
Three to four weeks previous to the study, eight of the animals received a sub-
axillary transplant of Barrett mammary adenocarcinoma. The tumor weights
averaged 688 mg. at the time of sacrifice. Fluorene-2,7-di-(sulfonamido-2'-
naphthalene)-S35, having a specific activity of 340,000 dpm/mg., was dissolved
in dilute sodium bicarbonate and ethanol, and administered by tail vein; each
mouse received 5 mg. of compound. Animals were sacrificed eight hours after
injection. The concentration ofradioactive material in the tissues was determined
by the method previously described (Argus, 1953).
To determine the cells responsible for the uptake of radioactive compound
by the liver and spleen, autoradiograms from these organs were made. Frozen
sections of the tissue were prepared approximately 10 microns thick. Strips of
Kodak, no-screen, X-ray film were exposed to these sections for from one to four
weeks. The example shown (Fig. 1) was exposed for one week and developed in
D19 for four minutes.
RESULTS AND DISCUSSION
A difference in the uptake per gram of tissue of compound by the spleen of
non-tumor as compared to tumor bearing C3H mice was found (Table I). The
concentration of radioactivity in the spleen of control mice was 1.8 times that
in tumor hosts. Thus the effect found for CAF1 mouse spleen could also be
demonstrated in a different strain with a different tumor.MARY F. ARGUS, KATHLEEN HEWSON AND FRANCIS E. RAY
TABLE I.-Distribution of Radioactivity at 8 Hoursfollowing Intravenous
Injection ofFluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35*
Average weight Concentration
of tissue (,ug. compound/g. tissue).
(mg.). A^
, ------ Tumor-bearing. Control. Concentration ratio.
Tumor- --------- Average control
Mice. Tissue. bearing. Control. Range. Average.t Range. Average.t Avg. tumor-bearing
C3H . Spleen . 202 99 . 242-304 273 446-556 501 . 1- 8
Liver . 1408 1182 . 786-1172 979 968-1363 1165 . 1-2
CAF1 . Spleen 135 78 . 220-394 307 - 1488 . 4-8
Liver . 1075 1038 . 644-760 702 - 1288 . 1.8
*Dose was 5 mg. compound per mouse.
t Value for CAF1 control represents 2 pooled animals; each other value represents average from
2 sets of 2 pooled animals.
A concentration ratio of 1.2 was found for the livers of C3H mice. This also
may represent a real difference but too much significance cannot be claimed since
the concentrations for control and tumor-bearing animals overlap.
In CAF1 males the concentration in the spleen of non-tumor mice was 4-8
times that in mice bearing the transplanted tumor; the liver of the controls held
1.8 times as much activity as did the spleen from tumor-bearers. Thus we have
a larger differential between the non-tumor and tumor-bearing CAF1 mice than
between non-tumor and tumor-bearing C3H mice.
The reason for this variance between the C3H and the CAF1 mice must be
sought in genetic differences between the two. The males of the C3H strain
develop spontaneous hepatomas (Agnew and Gardner, 1952). The CAF1 hybrids
are obtained from matings between BALB/c females and A/Jax males. Both of
these parent strains are susceptible to spontaneous lung tumors (Andervont,
1938). It would be expected that their offspring would also be susceptible, so
that all animals employed can be considered susceptible to spontaneous cancer.
Perhaps the difference is in the type of tumor. A proneness to spontaneous liver
tumor might well have a more profound effect on the uptake of a compound by
the liver, and probably the spleen, than would a propensity to lung cancer. Thus
it may be that the difference in concentration ratio in the uptake ofthe radioactive
compound is because the animals are susceptible to different types of spontaneous
tumors. On the other hand, two different transplanted tumors were employed.
Since they both displayed the same degree ofmalignancy it would not be expected
that there would be any great difference in the effect per se of a squamous cell
stomach carcinoma and a mammary carcinoma on the liver and spleen. The C3H
strain, however, does carry the milk factor even though the males do not spon-
taneously develop mammary cancer. It might well be, therefore, that a trans-
planted mammary tumor is not as foreign to the C3H male as is a transplanted
squamous cell carcinoma to the CAF1. This could result in the lesser differential
found in the uptake of the radioactive compound by the C3H strain.
EXPLANATION OF PLATE
FIG. 1.-Histological section stained with hematoxylin and eosin, and autoradiogram of
spleen from a C3H/Jax mouse following administration of fluorene-2,7-di-(sulfonamido-2'-
naphthalene)-S35.
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Autoradiograms.-For the liver, autoradiograms showed a diffuse uptake of
radioactive material, suggesting localization in the Kupffer cells. In the spleen
(Fig. 1) radioactivity was deposited in the red pulp in a pattern which just outlines
the Malpighian follicles. No qualitative difference in this pattern of distribution
was seen for the non-tumor and tumor-bearing mice. Dunn (1954a, 1954b) has
described an arrangement of the reticuloendothelial system in the mouse which
was demonstrated by Duqu6 in the C3H strain: surrounding the follicle is a well
developed "perifollicular collar" of reticuloendothelial cells one or two layers
thick; peripheral to this there is a "perifollicular halo" formed by reticulo-
endothelial cells inparallel rows. It appears to be these phagocytic reticulum cells
of the "perifollicular halo" that have taken up the radioactivity. This suggests
a difference in reticuloendothelial function of tumor-bearing mice as compared to
controls.
SUMMARY
Fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35 was administered by tail
vein to male C3H/Jax mice. Radioactivity was found to accumulate in the liver
and spleen of control mice to a greater extent than in these same organs of mice
bearing a transplanted Barrett mammary adenocarcinoma. This difference
between non-tumor and tumor-bearing mice of the C3H/Jax strain, however,
was not as great as that found between non-tumor and tumor-bearing CAF1/Jax
mice. Autoradiograms of the spleen showed the radioactivity to be deposited in
association with phagocytic reticuloendothelial cells outlining the Malpighian
follicles.
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